Show simple item record

dc.contributor.advisorTsygankov, Alexander
dc.creatorTashovski, Ivan
dc.date.accessioned2020-11-05T19:50:27Z
dc.date.available2020-11-05T19:50:27Z
dc.date.issued2016
dc.identifier.urihttp://hdl.handle.net/20.500.12613/3960
dc.description.abstractThe human immunodeficiency virus type-1 (HIV-1) is the major etiological agent of acquired immunodeficiency syndrome (AIDS), the cause of over 30 million deaths worldwide. Highly active antiretroviral therapy (HAART) has demonstrated great efficacy at suppressing viral load and is therefore the standard therapeutic treatment for HIV-1 infection. Noncompliance due to severe HAART-associated side effects significantly undermines therapeutic efficacy. Dronabinol, the synthetic form of the cannabinoid THC found in marijuana, is FDA-approved for countering some of these side effects. Studies have reported that cannabinoids restrict HIV-1 replication, although no mechanism has yet been proposed. Thus the purpose of this study was to characterize the effects of cannabinoids on HIV-1 infection and to determine the molecular basis of cannabinoid-induced viral suppression. By transcriptomic sequencing of T cells treated with cannabinoids, we have found that the expression of BAG6, a protein uncharacterized within the context of HIV-1 infection, was downregulated. To identify the role of this protein during infection, we knocked down BAG6 and were able to recapitulate the protective effects of cannabinoids by observing reduced severity of viral challenge. Moreover, we have also identified BAG6 to be a binding partner of two HIV-1 viral accessory proteins, Vif and Vpr. Importantly, we have discovered that Vpr mediates targeted degradation of BAG6 by leveraging the host proteasome during the early stages of the viral lifecycle, revealing a hitherto unknown function of this poorly-understood viral protein. We thus establish modulation of BAG6 expression as a novel mediator of the effects of cannaninoids on HIV-1 infection.
dc.format.extent148 pages
dc.language.isoeng
dc.publisherTemple University. Libraries
dc.relation.ispartofTheses and Dissertations
dc.rightsIN COPYRIGHT- This Rights Statement can be used for an Item that is in copyright. Using this statement implies that the organization making this Item available has determined that the Item is in copyright and either is the rights-holder, has obtained permission from the rights-holder(s) to make their Work(s) available, or makes the Item available under an exception or limitation to copyright (including Fair Use) that entitles it to make the Item available.
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.subjectMicrobiology
dc.subjectVirology
dc.subjectBiology, Molecular
dc.subjectCannabinoids
dc.subjectHiv-1
dc.subjectHost Factors
dc.titleBAG6 as a Novel HIV-1 Host Factor
dc.typeText
dc.type.genreThesis/Dissertation
dc.contributor.committeememberChin, Mario
dc.contributor.committeememberGanea, Doina
dc.contributor.committeememberEisenstein, Toby K.
dc.contributor.committeememberXiao, Weidong
dc.contributor.committeememberWard, Sara J.
dc.description.departmentMicrobiology and Immunology
dc.relation.doihttp://dx.doi.org/10.34944/dspace/3942
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.description.degreePh.D.
refterms.dateFOA2020-11-05T19:50:28Z


Files in this item

Thumbnail
Name:
TETDEDXTashovski-temple-0225E- ...
Size:
2.473Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record